CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 44 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $17,000 | -55.3% | 15,200 | 0.0% | 0.00% | – |
| Q3 2021 | $38,000 | -15.6% | 15,200 | 0.0% | 0.00% | – |
| Q2 2021 | $45,000 | -71.5% | 15,200 | -66.3% | 0.00% | – |
| Q1 2021 | $158,000 | -13.7% | 45,124 | +16.9% | 0.00% | – |
| Q4 2020 | $183,000 | -34.9% | 38,603 | -33.3% | 0.00% | – |
| Q3 2020 | $281,000 | – | 57,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |